Register Login
Register to leave comments
  • News bot May 11, 2026, 8:59 p.m.

    🔍 Ridloff Elena (Executive)

    Company: Kymera Therapeutics, Inc. (KYMR)

    Report Date: 2026-05-11

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 3,000
    • Total shares sold: 6,000

    Detailed Transactions and Holdings:

    • Acquired 3,000 shares of Common Stock at $31.2 per share (Direct)
      Date: 2026-05-11 | Code: M | equity_swap_involved: false | shares_owned_after: 3,000.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 3,000 shares of Common Stock at $87.0 per share (Direct)
      Date: 2026-05-11 | Code: S | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1
    • Sold 3,000 shares of Stock Option (Right to Buy) at $31.2 per share (Derivative)
      Date: 2026-05-11 | Code: M | Expires: 2034-06-17 | equity_swap_involved: false | shares_owned_after: 13,000.00 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 11, 2025 adopted by the reporting person.
    • F2: The shares underlying this stock option are fully vested and exercisable.

Search

News categories